These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

229 related items for PubMed ID: 22101790

  • 1. Inhibition of silibinin on migration and adhesion capacity of human highly metastatic breast cancer cell line, MDA-MB-231, by evaluation of β1-integrin and downstream molecules, Cdc42, Raf-1 and D4GDI.
    Dastpeyman M, Motamed N, Azadmanesh K, Mostafavi E, Kia V, Jahanian-Najafabadi A, Shokrgozar MA.
    Med Oncol; 2012 Dec; 29(4):2512-8. PubMed ID: 22101790
    [Abstract] [Full Text] [Related]

  • 2. Silibinin Inhibit Cell Migration through Downregulation of RAC1 Gene Expression in Highly Metastatic Breast Cancer Cell Line.
    Lashgarian HE, Adamii V, Ghorbanzadeh V, Chodari L, Kamali F, Akbari S, Dariushnejad H.
    Drug Res (Stuttg); 2020 Oct; 70(10):478-483. PubMed ID: 32791535
    [Abstract] [Full Text] [Related]

  • 3. Polymeric Delivery of siRNA against Integrin-β1 (CD29) to Reduce Attachment and Migration of Breast Cancer Cells.
    Meenakshi Sundaram DN, Kucharski C, Parmar MB, Kc RB, Uludağ H.
    Macromol Biosci; 2017 Jun; 17(6):. PubMed ID: 28160423
    [Abstract] [Full Text] [Related]

  • 4. Silibinin inhibits fibronectin induced motility, invasiveness and survival in human prostate carcinoma PC3 cells via targeting integrin signaling.
    Deep G, Kumar R, Jain AK, Agarwal C, Agarwal R.
    Mutat Res; 2014 Oct; 768():35-46. PubMed ID: 25285031
    [Abstract] [Full Text] [Related]

  • 5. A novel and selective inhibitor of PKC ζ potently inhibits human breast cancer metastasis in vitro and in mice.
    Wu J, Liu S, Fan Z, Zhang L, Tian Y, Yang R.
    Tumour Biol; 2016 Jun; 37(6):8391-401. PubMed ID: 26733166
    [Abstract] [Full Text] [Related]

  • 6. Cdc42 negatively regulates intrinsic migration of highly aggressive breast cancer cells.
    Zuo Y, Wu Y, Chakraborty C.
    J Cell Physiol; 2012 Apr; 227(4):1399-407. PubMed ID: 21618528
    [Abstract] [Full Text] [Related]

  • 7. Evaluation of silibinin on the viability, migration and adhesion of the human prostate adenocarcinoma (PC-3) cell line.
    Mokhtari MJ, Motamed N, Shokrgozar MA.
    Cell Biol Int; 2008 Aug; 32(8):888-92. PubMed ID: 18538589
    [Abstract] [Full Text] [Related]

  • 8. Nuclear SIPA1 activates integrin β1 promoter and promotes invasion of breast cancer cells.
    Zhang Y, Gong Y, Hu D, Zhu P, Wang N, Zhang Q, Wang M, Aldeewan A, Xia H, Qu X, Ring BZ, Minato N, Su L.
    Oncogene; 2015 Mar 12; 34(11):1451-62. PubMed ID: 24704834
    [Abstract] [Full Text] [Related]

  • 9. Silencing of D4-GDI inhibits growth and invasive behavior in MDA-MB-231 cells by activation of Rac-dependent p38 and JNK signaling.
    Zhang Y, Rivera Rosado LA, Moon SY, Zhang B.
    J Biol Chem; 2009 May 08; 284(19):12956-65. PubMed ID: 19269969
    [Abstract] [Full Text] [Related]

  • 10. Breast cancer cell migration is regulated through junctional adhesion molecule-A-mediated activation of Rap1 GTPase.
    McSherry EA, Brennan K, Hudson L, Hill AD, Hopkins AM.
    Breast Cancer Res; 2011 Mar 23; 13(2):R31. PubMed ID: 21429211
    [Abstract] [Full Text] [Related]

  • 11. Adhesion and migration of extracellular matrix-stimulated breast cancer.
    Bartsch JE, Staren ED, Appert HE.
    J Surg Res; 2003 Mar 23; 110(1):287-94. PubMed ID: 12697413
    [Abstract] [Full Text] [Related]

  • 12. Inhibitory effect of cathepsin K inhibitor (ODN-MK-0822) on invasion, migration and adhesion of human breast cancer cells in vitro.
    Vashum Y, Premsingh R, Kottaiswamy A, Soma M, Padmanaban A, Kalaiselvan P, Samuel S.
    Mol Biol Rep; 2021 Jan 23; 48(1):105-116. PubMed ID: 33294960
    [Abstract] [Full Text] [Related]

  • 13. 3,4-Methylenedioxy-β-nitrostyrene inhibits adhesion and migration of human triple-negative breast cancer cells by suppressing β1 integrin function and surface protein disulfide isomerase.
    Chen IH, Chang FR, Wu YC, Kung PH, Wu CC.
    Biochimie; 2015 Mar 23; 110():81-92. PubMed ID: 25593085
    [Abstract] [Full Text] [Related]

  • 14. IQGAP1 and NWASP promote human cancer cell dissemination and metastasis by regulating β1-integrin via FAK and MRTF/SRF.
    Cerutti C, Lucotti S, Menendez ST, Reymond N, Garg R, Romero IA, Muschel R, Ridley AJ.
    Cell Rep; 2024 Apr 23; 43(4):113989. PubMed ID: 38536816
    [Abstract] [Full Text] [Related]

  • 15. Silibinin inhibits prostate cancer invasion, motility and migration by suppressing vimentin and MMP-2 expression.
    Wu KJ, Zeng J, Zhu GD, Zhang LL, Zhang D, Li L, Fan JH, Wang XY, He DL.
    Acta Pharmacol Sin; 2009 Aug 23; 30(8):1162-8. PubMed ID: 19578386
    [Abstract] [Full Text] [Related]

  • 16. Effects of silibinin on growth and invasive properties of human ovarian carcinoma cells through suppression of heregulin/HER3 pathway.
    Momeny M, Ghasemi R, Valenti G, Miranda M, Zekri A, Zarrinrad G, Javadikooshesh S, Yaghmaie M, Alimoghaddam K, Ghavamzadeh A, Ghaffari SH.
    Tumour Biol; 2016 Mar 23; 37(3):3913-23. PubMed ID: 26482609
    [Abstract] [Full Text] [Related]

  • 17. Silibinin inhibits migration and invasion of breast cancer MDA-MB-231 cells through induction of mitochondrial fusion.
    Si L, Fu J, Liu W, Hayashi T, Nie Y, Mizuno K, Hattori S, Fujisaki H, Onodera S, Ikejima T.
    Mol Cell Biochem; 2020 Jan 23; 463(1-2):189-201. PubMed ID: 31612353
    [Abstract] [Full Text] [Related]

  • 18. A diterpenoid compound, excisanin A, inhibits the invasive behavior of breast cancer cells by modulating the integrin β1/FAK/PI3K/AKT/β-catenin signaling.
    Qin J, Tang J, Jiao L, Ji J, Chen WD, Feng GK, Gao YH, Zhu XF, Deng R.
    Life Sci; 2013 Nov 04; 93(18-19):655-63. PubMed ID: 24044886
    [Abstract] [Full Text] [Related]

  • 19. The apoptotic effects of silibinin on MDA-MB-231 and MCF-7 human breast carcinoma cells.
    Bayram D, Çetin ES, Kara M, Özgöçmen M, Candan IA.
    Hum Exp Toxicol; 2017 Jun 04; 36(6):573-586. PubMed ID: 27402681
    [Abstract] [Full Text] [Related]

  • 20. Silibinin inhibits Wnt/β-catenin signaling by suppressing Wnt co-receptor LRP6 expression in human prostate and breast cancer cells.
    Lu W, Lin C, King TD, Chen H, Reynolds RC, Li Y.
    Cell Signal; 2012 Dec 04; 24(12):2291-6. PubMed ID: 22820499
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.